In Vitro ADMET Laboratories LLC – Trademark Portfolio

Entity Type: 16

In Vitro ADMET Laboratories LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. The owner is based in Columbia, MD.

www.invitroadmet.com

9221 Rumsey Road Suite 8

Columbia, MD 21045

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

In Vitro ADMET Laboratories LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

40
Treatment & Processing (1 filing)

Treatment of materials

Frequently Asked Questions

How many trademarks does In Vitro ADMET Laboratories LLC have?

In Vitro ADMET Laboratories LLC has 2 U.S. trademarks filed with the USPTO.

What trademark classes does In Vitro ADMET Laboratories LLC file in?

In Vitro ADMET Laboratories LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is In Vitro ADMET Laboratories LLC's trademark registration success rate?

In Vitro ADMET Laboratories LLC has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.